10x Genomics, Inc. (NASDAQ:TXG) Receives $18.85 Average PT from Analysts
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have been given a consensus recommendation of “Hold” by the sixteen analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating on the […]
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have been given a consensus recommendation of “Hold” by the sixteen analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating on the […]
